TB
Theravance Biopharma Inc (TBPH)
NASDAQ·Healthcare·Biotechnology
$17.04
+0.03%
Mkt Cap $882.63M
Analyst Ratings
Buy
0
Hold
4
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
Implied Upside
-9.0%
Consensus $15.50 vs current $17.04
NASDAQ·Healthcare·Biotechnology
$17.04
+0.03%
Mkt Cap $882.63M
Buy
0
Hold
4
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
-9.0%
Consensus $15.50 vs current $17.04